A Study To Investigate The Taste Of Crizotinib Liquid In Trained Healthy Adult Volunteers
Completed · Phase 1
Conditions studied: Healthy
In brief
An oral-liquid, pediatric form of crizotinib designed for use by pediatric patients is being tested for its' palatability in adults.
Key facts
- Study ID
- NCT01125904
- Run by
- Pfizer
- People needed
- 5
- Starts
- 2010-06-01
- Expected to finish
- 2010-06-01
- Last updated by the study team
- 2010-07-23
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy male and/or female of non childbearing potential subjects between the ages of 18 and 75 years, inclusive.
- Subjects must be trained sensory panelists.
- An informed consent document signed and dated by the subject or a legally acceptable representative.
- Subjects who are willing and able to comply with scheduled visits, product evaluations, laboratory tests, and other study procedures.
You may not qualify if…
- A history of clinically significant hematological, renal, endocrine, pulmonary , glaucoma, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, allergic disease (excluding untreated, asymptomatic seasonal allergies at the time of product evaluation) as evaluated through a medical history.
- A history of hypersensitivity to any inactive ingredients employed in the formulation(s).
- Receiving treatment with an investigational drug within 28 days preceding any of the product evaluations for this study.
- Participation in a product taste evaluation (ie, 'sip and spit' type taste evaluation) involving an active pharmaceutical ingredient (API) within 5 half lives of that API.
- Unwilling or unable to comply with the Lifestyle guidelines described in this protocol.
Where it is running
- Pfizer Investigational Site — Woburn, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.